Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

<< Previous

Bullboard Posts

Next >>

Post by edroseon Nov 23, 2019 9:09am

102 Views

Post# 30385098

Look st compensation they gave themselves after takeover

Millions of dollars at a time they said we had no money. This is a fact and it’s written

also look at the % of pli total revenue in 2017 they gave themselves ie the board sickening

<< Previous

Bullboard Posts

Next >>

FLYHT and WestJet partner on weather forecasting